Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV
PRO-QINF-3006
Phase 3 mab active
Quick answer
Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV for Influenza is a Phase 3 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Influenza
- Phase
- Phase 3
- Modality
- mab
- Status
- active